These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20623273)

  • 1. Cell-based assays: fuelling drug discovery.
    Michelini E; Cevenini L; Mezzanotte L; Coppa A; Roda A
    Anal Bioanal Chem; 2010 Sep; 398(1):227-38. PubMed ID: 20623273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting in vitro and in vivo bioluminescence for the implementation of the three Rs principle (replacement, reduction, and refinement) in drug discovery.
    Michelini E; Cevenini L; Calabretta MM; Calabria D; Roda A
    Anal Bioanal Chem; 2014 Sep; 406(23):5531-9. PubMed ID: 24908412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of original research contributions toward FDA-approved drugs.
    Patridge EV; Gareiss PC; Kinch MS; Hoyer DW
    Drug Discov Today; 2015 Oct; 20(10):1182-7. PubMed ID: 26113307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in microfluidics for drug discovery.
    Lombardi D; Dittrich PS
    Expert Opin Drug Discov; 2010 Nov; 5(11):1081-94. PubMed ID: 22827746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Label-free screening assays: a strategy for finding better drug candidates.
    Lunn CA
    Future Med Chem; 2010 Nov; 2(11):1703-16. PubMed ID: 21428840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
    Bergsdorf C; Ottl J
    Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches for high-throughput pharmacokinetic screening of low-molecular-weight drug candidates.
    Fontana S
    Expert Opin Drug Metab Toxicol; 2014 Feb; 10(2):139-42. PubMed ID: 24329157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent trends and observations in the design of high-quality screening collections.
    Renner S; Popov M; Schuffenhauer A; Roth HJ; Breitenstein W; Marzinzik A; Lewis I; Krastel P; Nigsch F; Jenkins J; Jacoby E
    Future Med Chem; 2011 Apr; 3(6):751-66. PubMed ID: 21554080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid-phase biological assays for drug discovery.
    Forsberg EM; Sicard C; Brennan JD
    Annu Rev Anal Chem (Palo Alto Calif); 2014; 7():337-59. PubMed ID: 25000820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ion channel drug discovery: challenges and future directions.
    Wickenden A; Priest B; Erdemli G
    Future Med Chem; 2012 Apr; 4(5):661-79. PubMed ID: 22458684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragment-based approaches in drug discovery and chemical biology.
    Scott DE; Coyne AG; Hudson SA; Abell C
    Biochemistry; 2012 Jun; 51(25):4990-5003. PubMed ID: 22697260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-Based Assay Design for High-Content Screening of Drug Candidates.
    Nierode G; Kwon PS; Dordick JS; Kwon SJ
    J Microbiol Biotechnol; 2016 Feb; 26(2):213-25. PubMed ID: 26428732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Riboswitch-based antibacterial drug discovery using high-throughput screening methods.
    Penchovsky R; Stoilova CC
    Expert Opin Drug Discov; 2013 Jan; 8(1):65-82. PubMed ID: 23163232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Discovery Goes Three-Dimensional: Goodbye to Flat High-Throughput Screening?
    Eglen RM; Randle DH
    Assay Drug Dev Technol; 2015 Jun; 13(5):262-5. PubMed ID: 26121065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-protein interaction modulator drug discovery: past efforts and future opportunities using a rich source of low- and high-throughput screening assays.
    Gul S; Hadian K
    Expert Opin Drug Discov; 2014 Dec; 9(12):1393-404. PubMed ID: 25374163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting pluripotent stem cell technology for drug discovery, screening, safety, and toxicology assessments.
    McGivern JV; Ebert AD
    Adv Drug Deliv Rev; 2014 Apr; 69-70():170-8. PubMed ID: 24309014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2D and 3D cell microarrays in pharmacology.
    Gidrol X; Fouqué B; Ghenim L; Haguet V; Picollet-D'hahan N; Schaack B
    Curr Opin Pharmacol; 2009 Oct; 9(5):664-8. PubMed ID: 19520607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving drug discovery with contextual assays and cellular systems analysis.
    Westwick JK; Lamerdin JE
    Methods Mol Biol; 2011; 756():61-73. PubMed ID: 21870220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of implementing cell-based pathway reporter assays in early high-throughput screening assay cascades for antibody drug discovery.
    Smith AJ; Hancock MK; Bi K; Andrews J; Harrison P; Vaughan TJ
    J Biomol Screen; 2012 Jul; 17(6):713-26. PubMed ID: 22496095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.